Company intelligence / Profile preview

ReciPharm Advanced Bio

Watertown, MA, USArecipharm.com ↗
Ownership
Private
Development stage
Other
01

Overview

ReciBioPharm is a leading Contract Development and Manufacturing Organization (CDMO) specializing in advanced therapy medicinal products (ATMPs) and biologics. As the dedicated biologics division of the Recipharm group, the company provides end-to-end services for complex modalities including mRNA, viral vectors, plasmid DNA, and live biotherapeutic products. It was established through the strategic integration of specialized entities such as Arranta Bio, Vibalogics, and GenIbet to address the growing demand for outsourced manufacturing in the cell and gene therapy sectors. ReciBioPharm operates a global network of state-of-the-art facilities in the United States and Europe, supporting clients from early-stage process development through to commercial-scale production. The company's capabilities include comprehensive analytical testing, process optimization, and sterile fill-finish services.

Modalities
mRNA-based drugsViral vector therapyGene therapyLive biotherapeutic product therapyMonoclonal antibodyRecombinant proteinDNA vaccine
Industry
Contract Manufacturing Organization
02

Partnerships

Beyond the preview

Go deeper on ReciPharm Advanced Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ReciPharm Advanced Bio.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call